Suppr超能文献

粪便脂肪浓度作为胰腺功能不全筛查试验的效用。

Utility of fecal fat concentrations as screening test in pancreatic insufficiency.

作者信息

Roberts I M, Poturich C, Wald A

出版信息

Dig Dis Sci. 1986 Oct;31(10):1021-4. doi: 10.1007/BF01300253.

Abstract

We explored the utility of fecal fat concentration (gram fecal fat per 100 gram wet stool weight) as a screening test for pancreatic steatorrhea. Data were analyzed on 24 patients with pancreatic insufficiency and steatorrhea, six groups of patients (N = 70) with nonpancreatic causes of steatorrhea, and 31 controls without steatorrhea. Patients with pancreatic steatorrhea had significantly (P less than 0.05) higher mean fecal fat concentrations than all groups except for patients with hepatobiliary disease. Using a fecal fat concentration of greater than 9.5% as a cutoff point in all patients with steatorrhea, the test was 41.7% sensitive and 92.0% specific for the diagnosis of pancreatic insufficiency. For patients with fecal fat excretion greater than 20 g/day, the test increased in sensitivity to 61.5% but specificity dropped to 85.3%. Measurements of fecal fat concentrations are therefore only moderately helpful, and further evidence is required to secure a diagnosis of pancreatic steatorrhea.

摘要

我们探讨了粪便脂肪浓度(每100克湿粪便重量中的粪便脂肪克数)作为胰腺性脂肪泻筛查试验的效用。分析了24例胰腺功能不全并伴有脂肪泻的患者、六组脂肪泻由非胰腺原因引起的患者(N = 70)以及31例无脂肪泻的对照者的数据。胰腺性脂肪泻患者的平均粪便脂肪浓度显著高于(P < 0.05)除肝胆疾病患者外的所有组。在所有脂肪泻患者中,以粪便脂肪浓度大于9.5%作为临界值,该试验对胰腺功能不全诊断的敏感性为41.7%,特异性为92.0%。对于粪便脂肪排泄量大于20克/天的患者,该试验的敏感性提高到61.5%,但特异性降至85.3%。因此,粪便脂肪浓度测量仅具有一定的帮助,还需要进一步的证据来确诊胰腺性脂肪泻。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验